Wexford Capital’s Tricida, Inc. Common Stock TCDA Stock Holding History

Wexford Capital’s Portfolio TCDA Stock Details TCDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-5,493	Closed	-$39K	–	389
2020 Q4	$39K	Buy	+5,493	New	+$42.1K	0.01%	270

Other funds holding TCDA

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

LPC

Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Wexford Capital's TCDA Position: Q1 2021 in Review

Wexford Capital sold out of Tricida, Inc. Common Stock (TCDA) in Q1 2021, closing a stake of 5,493 shares — an estimated $39K sold.

Wexford Capital first reported a position in TCDA in Q4 2020 and held it in 1 quarter. The position peaked at $39K in Q4 2020. 104 funds tracked by Wall St. Rank hold TCDA as of Q1 2021.

Wexford Capital reported no remaining Tricida, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
Wexford Capital sold 5,493 Tricida, Inc. Common Stock shares in Q1 2021, an estimated $39K.
Wexford Capital first reported a position in Tricida, Inc. Common Stock in Q4 2020 and held it in 1 quarter.
Wexford Capital's Tricida, Inc. Common Stock position peaked at $39K in Q4 2020.
104 funds tracked by Wall St. Rank held Tricida, Inc. Common Stock as of Q1 2021.

Based on Wexford Capital's 13F filing for Q1 2021, filed 13 May 2021.